According to some projections for the United States, the medical cannabis market will reach a peak in 2024, with around 9.3 billion U.S. dollars. After that, a phase of stagnation and even decline is expected in the following years. This is partly because medical sales tend to fall when states start allowing adult-use sales after previously allowing medical-use sales.

The Cannabis Industry Report is Segmented by Product Type (Capsules, Concentrates, Edibles, and Other Product Types), Application (Medical and Recreational), Compound Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Balanced THC and CBD), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Report Offers Market Size and Forecasts for all the Above Segments in Value (USD).

Medical cannabis is expected to make up the majority of the legal cannabis market in Oceania in 2022. Sales of legal adult use cannabis are projected at 5.4 million U.S. dollars in that year and are expected to grow to 18.8 million dollars by 2025.

This statistic shows a forecast of Oregon's share of the total U.S. legal cannabis market from 2016 to 2025. Oregon's market share in legal cannabis is predicted to decrease from 8.7 percent in 2016 to 4.3 percent in 2025.

By 2025, it is estimated that the state of California will have the highest share of the legal cannabis market in the United States, at a value of 20 percent. Florida is estimated to have an eight percent market share in 2025.

Snapshot img

Cannabis Testing Market Size 2024-2028

The cannabis testing market size is forecast to increase by USD 2.05 billion at a CAGR of 15.23% between 2023 and 2028.

The market is experiencing significant growth due to various trends and factors. One of the primary drivers is the increasing use of cannabis for medical purposes, leading to a rise in demand for accurate and reliable testing services. Another trend is the emergence of luxury cannabis products, which require rigorous testing using high-performance liquid chromatography (HPLC) and chromatography to ensure consistency and quality. 
However, the high cost of analytical products poses a challenge for smaller players in the market. Producers and retailers must invest in advanced testing technologies to meet regulatory requirements and consumer demand for safe and effective cannabis products. .

What will be the Size of the Cannabis Testing Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to increasing demand for automation software and innovation in ensuring product safety and regulatory compliance. With a focus on accuracy and consumer safety, companies are investing heavily in research and development, data analysis, and training to stay ahead of industry trends. Automation and standardization of testing protocols are key priorities, enabling faster turnaround times and cost savings.



Sensitivity and specificity are crucial factors in cannabis testing, requiring advanced equipment and rigorous quality control measures. Safety and accreditation are paramount, driving the need for certification and adherence to best practices. Regulations continue to evolve, necessitating ongoing education and adaptation. Market analysis and data management are essential for understanding consumer preferences and staying competitive. Outsourcing testing services to specialized providers offers cost savings and expertise. The future of the market lies in continued innovation, ensuring traceability, and providing comprehensive reporting and chain of custody solutions.

How is this Cannabis Testing Industry segmented and which is the largest segment?

The cannabis testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Consumables
  Instruments
  Software


End-user

  Cannabis cultivators/growers
  Cannabis drug manufacturers
  Others


Type

  Potency Testing
  Terpene Profiling
  Residual Solvent Screening
  Heavy Metal Testing
  Mycotoxin Testing
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Product Insights

The consumables segment is estimated to witness significant growth during the forecast period.

The market involves the utilization of analytical laboratories, instruments, and consumables for the analysis of cannabis and cannabis-infused products. This testing is essential to ensure product quality, potency, and consumer safety. Regulatory standards mandate the testing for pesticides, heavy metals, residual solvents, and contaminants. Chromatographic methods, such as gas and liquid chromatography, are commonly used for the testing of cannabinoid content, including cannabidiol (CBD) and tetrahydrocannabinol (THC). UV spectrometric analysis and mass spectrometry are also used for identifying and quantifying various cannabis compounds. The cannabis industry, including medical and adult use, requires rigorous testing processes to meet consumer demands and regulatory requirements. Sigma-Aldrich, a subsidiary of Merck, is a significant supplier of consumables, including glassware, labware, and reagents, for the market.

Get a glance at the Cannabis Testing Industry report of share of various segments Request Free Sample

The consumables segment was valued at USD 715.30 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 49% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market dominates the global cannabis testing industry due to the legalization of cannabis for medical and adult use. The therapeutic potential of cannabis in alleviating symptoms of diseases such as epilepsy, cancer, and MS drives advocacy and political support. Countries like Canada are set to legalize cannabis for taxation. The market expansion in North America is primarily driven by the rising application of cannabis-infuse

According to some projections for the United States, the medical cannabis market will reach a size of over 11 billion U.S. dollars in 2025. Almost half of that amount would be generated from flower products, around 5.4 billion dollars.

Cannabis Industry Software Market size was valued at USD 1207.91 Million in 2024 and is projected to reach USD 9962.94 Million by 2031, growing at a CAGR of 30.18% from 2024 to 2031.

Global Cannabis Industry Software Market Drivers

Requirements for Regulatory Compliance: The cannabis business works in a complicated regulatory landscape with strict guidelines controlling sales, distribution, and growing. Cannabis sector software, which automates compliance procedures, keeps thorough audit trails, and guarantees adherence to legal standards, is essential in assisting firms in navigating these regulatory hurdles. The need for software solutions that make compliance management easier is growing as regulatory frameworks continue to change and tighten.

Supply Chain Optimization: The production, processing, distribution, and retail phases of the cannabis supply chain are all included. Software for the cannabis sector offers comprehensive solutions to improve productivity, visibility, and traceability at every stage of the supply chain. With capabilities like demand forecasting, logistics tracking, and inventory management, these software solutions help organizations save waste, optimize workflows, and guarantee product quality and safety all the way through the supply chain.

Operational Efficiency and Scalability: To keep a competitive edge as the cannabis market grows and competition heats up, businesses are putting more and more effort into enhancing operational efficiency and scalability. Software for the cannabis sector provides all-inclusive solutions for handling various areas of business operations, including as customer relationship management (CRM), point-of-sale (POS) systems, facility automation, and cultivation management. These software platforms help firms extend their operations efficiently and adjust to shifting market dynamics by automating manual procedures, maximizing resource utilization, and offering real-time analytics insights.

The Cannabis Pharmaceuticals Market Share size and share are expected to exceed USD 357.96 billion by 2034, with a compound annual growth rate (CAGR) of 52.4% during the forecast period

The cannabis market in the state of California is projected to be valued at 7.7 billion U.S. dollars by the year 2022. The statistic illustrates the legal cannabis market size estimates in select U.S. states for the year 2022.

The global cannabis testing market size reached USD 1,593.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,194.1 Million by 2033, exhibiting a growth rate (CAGR) of 10.78% during 2025-2033. The increasing awareness among the masses about the benefits of cannabis testing, rising number of advanced laboratories, and the growing utilization of laboratory information management system (LIMS) represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the global cannabis testing market, along with forecasts at the global, regional, and country level from 2025-2033. Our report has categorized the market based on product type, test type, and end user.

According to Cognitive Market Research, the global cannabis extraction market size will be USD 12542.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 19.60% from 2024 to 2031. North America held the major market share for more than 40% of the global revenue with a market size of USD 5017.00 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.8% from 2024 to 2031. Europe accounted for a market share of over 30% of the global revenue with a market size of USD 3762.75 million. Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 2884.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.6% from 2024 to 2031. Latin America had a market share of more than 5% of the global revenue with a market size of USD 627.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.0% from 2024 to 2031. Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 250.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.3% from 2024 to 2031. The non-solvent extraction is the fastest growing segment of the cannabis extraction industry Market Dynamics of Cannabis Extraction Market Key Drivers for Cannabis Extraction Market Legalization of cannabis in several countries to drive market growth The legalization of cannabis in various countries is a key driver for the cannabis extraction market. As more governments approve cannabis for medicinal and recreational use, the demand for high-quality extracts increases significantly. Legalization enables easier access to the plant, fuels investment in advanced extraction technologies, and supports the growth of research and development in cannabis-based products. This regulatory shift creates a broader customer base, leading to higher consumption of cannabis oils, concentrates, and edibles. Additionally, it allows companies to operate with fewer restrictions, encouraging innovations in extraction methods. As a result, the growing legal cannabis landscape will positively impact the market by increasing production capabilities and fostering the development of new cannabis-derived products, driving overall market expansion. Increasing demand for medicinal cannabis products to boost market growth The increasing demand for medicinal cannabis products is significantly boosting the cannabis extraction market. Patients and healthcare providers are increasingly turning to cannabis extracts, such as CBD oils, due to their therapeutic potential in treating a variety of medical conditions like chronic pain, anxiety, epilepsy, and multiple sclerosis. This growing acceptance in the medical field encourages pharmaceutical companies to invest in research and develop targeted formulations using cannabis extracts. As the medicinal benefits of cannabinoids gain more clinical validation, demand is set to rise, particularly for high-quality, precise-dose extracts. This trend will drive the growth of extraction technologies, as companies seek to meet stringent medical-grade product standards, while also boosting overall production to cater to the burgeoning medical cannabis industry. Restraint Factor for the Cannabis Extraction Market Data security and privacy concerns to limit market growth Inconsistent product quality due to different extraction methods is a significant restraint in the cannabis extraction market. Each extraction method—whether solvent-based or solvent less—produces varying results in terms of cannabinoid content, purity, and overall potency. For instance, CO2 extraction might yield a higher purity, while ethanol extraction may produce higher quantities but with residual solvents. Such inconsistencies can affect the final product’s efficacy, making it difficult to maintain uniform standards across batches. This lack of consistency can undermine consumer trust, particularly in medicinal applications where precise dosage and reliability are critical. Additionally, regulatory bodies may impose stricter quality controls, leading to increased production costs for manufacturers trying to ensure standardized output. These challenges can limit the market’s growth as consumers and regulators demand greater consistency and safety. Impact of Covid-19 on the Cannabis Extraction Market The COVID-19 pandemic negatively impacted the cannabis extraction market due to disruptions in supply cha...

According to Cognitive Market Research, the cannabis seeds market size will be USD XX Billion in 2024 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2030. Market Dynamics: Cannabis Market

Key Drivers-

Awareness among people about cannabis seeds' benefits drives the market-

Cannabis seeds are a nutritional source rich in high-value nutrients such as proteins, with good digestibility and essential amino acids, polyunsaturated fatty acids, fiber, minerals, and vitamins. They treat chronic pain, lower the risk of heart disease, and enhance neurological and other problems. cannabis seeds are also a rich source of health-promoting antioxidants and phytochemicals that may be useful in supporting health and aiding the transition to plant-based diets. Additionally, products of cannabis seeds like cannabidiol (CBD) oil are a cannabinoid that is mixed with a carrier oil to make CBD oil. It claims that the oil benefits various health problems and regulates anxiety, mood, and appetite. CBD might help treat anxiety disorders, although there have not been many trials to look at CBD's anxiety-relieving effects in humans. For instance, in one study, 57 men took either CBD oil or a sugar pill with no CBD (placebo) before a public speaking event.15 The researchers assessed the participants' anxiety levels using blood pressure and heart rate measures. The researchers also used a reliable test for mood states called the Visual Analog Mood Scale. The men who took 300 milligrams (mg) of CBD oil reported less anxiety than the men who were given a placebo; however, the men who took 100 or 600 mg of CBD oil did not experience the same effects. This trial was limited by a small sample size and only enrolled men, so more data is needed to see if CBD has a similar impact on women. (source:https://www.verywellhealth.com/cbd-oil-benefits-uses-side-effects-4174562)

Therapeutic benefits of cannabis seeds drive the growth of the global cannabis seeds market.

The therapeutic use of cannabinoids treated numerous diseases such as -inflammation, neurodegenerative disorders, anorexia, pain, cardiovascular disorders, cancer, obesity, epilepsy, and cancer. Also, the use of cannabis for chemotherapy-induced nausea and vomiting may be the best-known and accepted use of cannabis by healthcare professionals, pain management is the most common reason for use among the medical marijuana states that keep records (although New Jersey does not accept chronic pain as an acceptable use). For example, the most common conditions for which medical cannabis is used in Colorado and Oregon are pain, and spasticity associated with multiple sclerosis, nausea, posttraumatic stress disorder, cancer, epilepsy, cachexia, glaucoma, HIV/AIDS, and degenerative neurological conditions. For instance-, Light et al. (2014) reported that 94 percent of Colorado medical marijuana ID cardholders indicated “severe pain” as a medical condition. Likewise, Ilgen et al. (2013) reported that 87 percent of participants in their study were seeking medical marijuana for pain relief. (source:https://www.ncbi.nlm.nih.gov/books/NBK425767/)

Restraint-

The legalization of cannabis seeds is a major issue in many countries- There is a trace amount of THC (tetrahydrocannabinol) found in cannabis. It is a psychoactive compound used to manage and treat chemotherapy-induced nausea and vomiting., consuming large amounts of cannabis makes you high. That’s the reason Cannabis would then be available to the adult general population for purchase and use at will, similar to tobacco and alcohol. State legislature decriminalized cannabis because the act of removing criminal sanctions against an act, article, or behavior. the legal system would not prosecute a person for possession under a specified amount. Instead, the penalties would range from no penalties at all to civil fines, drug education, or drug treatment. Decriminalization of cannabis means it would remain illegal, For instance- Cannabis is the most commonly used illicit drug in the US. Data from The National Survey on Drug Use and Health indicate that 44% of males and 35% of females have used marijuana at least once in their lifetime. More recent studies suggest that regular use of marijuana/cannabis is increasing. Data from the National Survey on Drug Use and Health indicate that in persons over the age of 12years,...

[223+ Pages Report] Global cannabis in food and beverage market size & share estimated to reach USD 2,818 Million by 2026, representing a CAGR of 26.6% between 2021 and 2026. The cannabis plant is frequently referred to as hemp, however, this name refers to just the types of Cannabis that are grown for non-drug purposes.

The market for Cannabis Extract Machine will is USD 8497.5 Million worldwide in 2023, based on Cognitive Market Research, and will increase at a 15.5% compound annual growth rate (CAGR) between 2023 and 2030.

The market for cannabis extract machines will reach USD 8497.5 Million worldwide in 2023.
Favourable Government regulations for cannabis use will expand markets for manufacturers of CBD extraction equipment
Recreational cannabis dominates the majority of this market in this industry.
The sub/supercritical CO2 extraction machine category led the market in 2023.
According to Cognitive Market Research, North America ruled the market in 2023 and contributed more than 35% of global revenue as a result of various factors.

Favourable Government Rules for Cannabis Use Will Open Up Markets for CBD Extraction Device Suppliers

Over the past ten years, there has been a significant transformation in the cannabis sector. Legalizing CBD and cannabis in many nations will turn out to be one of the most important socioeconomic movements.

Twenty nations, including the USA, Brazil, South Korea, Australia, and others, have legalized marijuana in some form in the past two years, including CBD products. Additionally, ten nations in total, including Mexico, Canada, and South Africa, have legalized cannabis for adult use, a rise of nearly two times from 2019.

(Source:www.unodc.org/documents/data-and-analysis/Focus/WDR20_Booklet_4_cannabis_web.pdf)

With greater lawful access to cannabis products, the market for CBD extraction equipment is still growing favorably. Regulations and societal standards will change significantly as a result of this. Additionally, supportive government regulations, government funding for private research and medical institutions, and rising industry R&D expenditures will all contribute to boosting popularity of CBD extract machinery.

Market Dynamics of Cannabis Extract Machine

Equipment Sales for CBD Extraction Will Be Affected by Increasing Price Complexity and Related Extraction Risks

The main obstacles for the market for CBD extraction equipment are thought to be high production costs and a lack of important raw materials. Due to the greater production costs and the use of pricey materials that are more robust and have a longer lifespan, this leads to pricing complexity. Furthermore, extraction techniques use flammable liquids and gases that release hazardous gases. Additionally, an explosion can easily happen as a result of improper equipment design, modification, maintenance, and installation. In order to get beyond this obstacle and create better CBD extraction machinery and goods, research can be crucial in this situation.

Impact of COVID-19 on the Cannabis Extract Machines Market

All different kinds of businesses have been impacted by the corona virus (COVID-19) pandemic and lockdown in a number of different countries around the world. The private healthcare sector is suffering significantly as a result of the COVID-19 outbreak. The corona virus outbreak has had a negative impact on the development, production, and availability of raw materials, notably in the private sector. Introduction of Cannabis Extract Machine

The extraction of cannabinoids from cannabis is done using a cannabis extract machine. The cannabinoids that have been extracted can subsequently be employed in a variety of products, such as cannabis for both medical and recreational uses. Sub/supercritical CO2 extraction machines, ethanol extraction machines, hydrocarbon extraction machines, solvent-free extraction machines, and other forms of cannabis extract machines are just a few of the many varieties of extractors available.

These advancements give companies the ability to provide clients with more customised products and services, which helps the cannabis extract machine market flourish.

For instance, A variety of extraction equipment for cannabis and other botanicals is offered by Eden Labs, which has a $25 million sales income. Production of equipment using CO2 extraction technology by Apeks Supercritical has resulted in sales of $45 million.

(Source:www.edenlabs.com/)

[223+ Pages Report] Global legal marijuana market size & share estimated to generate revenue worth USD 97 Billion by the end of 2026, representing a CAGR of 28% between 2021 and 2026. Cannabis oil is becoming increasingly popular, particularly in nations where marijuana for medical purposes is permitted.

The Global Cannabis Concentrate Market in 2019 probably surpasses USD 1,785 million and is projected to reach around USD 5,940 million by 2026. The anticipated CAGR for the global cannabis concentrate market is around 17% from 2020 to 2026.

This statistic shows a forecast of Massachusetts' share of the total U.S. legal cannabis market from 2016 to 2025. Massachusetts' market share in legal cannabis is predicted to increase from 0.8 percent in 2016 to 5.7 percent in 2025.

The legal cannabis market has had explosive growth since several states in the United States legalized recreational consumption. With Canada legalizing recreational consumption nationwide and the growing popularity of the plant in the United States, the global legal cannabis market is set to reach over 63 billion dollars in value by 2024.

The legal landscape

Since 1970’s passage of the Controlled Substances Act, cannabis has been outlawed as a Schedule I drug (the most restrictive of drug categories) in the United States. Despite legalization on a state level, cannabis is still federally illegal to possess, manufacture and sell. In 2012, Washington and Colorado became the first two states to legalize recreational use of cannabis. Today, recreational cannabis use is legal in 10 states and medical use is legal in 33.

Where the market is

California had the most sales of legal cannabis in the United States in 2018. Two and a half billion dollars were spent on cannabis in the state. Colorado’s more mature market brought in 1.5 billion. By 2025, California is forecast to be responsible for 27.4 percent of the entire U.S. legal market. The black market is still strong, even in legal states. In California in particular, where the price of a legal gram of marijuana is often substantially higher than black market prices, the total legal and illicit market was roughly 5.6 billion dollars.

Statistics illustrates market overview of hemp (cannabis sativa l.); processed (other than retted) (but not spun), true hemp tow and waste (including yarn waste and garnetted stock) in Cambodia from 2007 to 2024.